Endpoints News 19. Mai 2026 Relay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
Endpoints News 19. Mai 2026 BioMarin's rare disease therapy shows no clinical benefit in Phase 3 test
Endpoints News 18. Mai 2026 Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report
Endpoints News 18. Mai 2026 Design Therapeutics' Friedreich's ataxia data; Vincentage's obesity results from China
Endpoints News 18. Mai 2026 FDA approves AstraZeneca’s baxdrostat for certain patients with hypertension